Support for you and your patients

The UNMOL Patient Support Program has supported more than 40,000* patients and covers upto 80% of the total treatment cost of patients. It has disbursed over Rs. 18 billion in free cost care and is designed to provide personalized services for patients, including:

 

  1. Helps facilitate access to, and coordinates with infusion hospitals.
  2. Answer questions you may have regarding infusion cycles.
  3. Managing funding and access.

*Data available on file.

Diseases we support through UNMOL:1-9
Please click on each disease area to look for the products and their offerings.
Breast Cancer

Pakistan has the highest incidence of breast cancer amongst Asian countries. One in nine women is at risk of being diagnosed with breast cancer during their lifetime. 109 women die every 24 hours due to breast cancer in Pakistan resulting in iver 40,000 deaths a year.
Lung Cancer

In 2020, lung cancer accounted for 10,538 new cases from both sexes and all ages combined constituting approximately 5.9% of all new cancer cases. This makes lung cancer the second most common cancer in men and third most common cancer in both sexes combined in Pakistan.
Liver Cancer

The commonest primary liver tumor is hepatocellular carcinoma [HCC] (approximately 75%). In Pakistan, prevalence of HCC varies from 3.7% - 16% of malignant tumours with viral hepatitis associated cirrhosis being the commonest cause.
Ovarian Cancer

There were more than 4,000 new cases of ovarian cancer in Pakistan in 2020 and nearly 3,000 deaths from this type of cancer. Ovarian cancer is a leading gynecological malignancy and the majority of cases occur in the 50 – 59 year age group.

 

Avastin

 
Cervical Cancer

Cervical cancer ranks as the 3rd most frequent cancer among women in Pakistan and the 2nd most frequent cancer among women between 15 and 44 years of age. About 0.5% of women in the general population are estimated to harbor cervical Human Papillomavirus (HPV – 16/18) infection at a given time, and 88.1% of invasive cervical cancers are attributed to HPVs 16 or 18.

 

Avastin
 
Multiple Sclerosis

1 in every 3,000 people worldwide live with MS. In Pakistan, the estimated number of MS patients is about 10,000. MS disproportionately affect women, depriving them of their most productive years.
Rheumatoid Arthritis

In 2019, 18 million people worldwide were living with rheumatoid arthritis. About 70% of people living with rheumatoid arthritis are women, and 55% are older than 55 years.
Spinal Muscular Atrophy

Spinal Muscular Atrophy (SMA) is a severe neuromuscular disease and is the leading genetic cause of infant death. There are approximately 500 – 700 patients of SMA in Pakistan.
Lymphoma

Lymphoma is the most commonly occurring blood cancer and the third most common childhood cancer. One million people around the world are living with lymphoma today, yet many people are still unaware of lymphoma and that it is a life-threatening form of cancer.

A Primary Point of Contact

At any point during your treatment, you can speak to the representative by calling the UNMOL Call Centre at +92 340 558 6665 from Monday - Friday (9 AM to 5PM PST).

In case of any adverse events or safety queries, please contact us at: pakistan.drug_safety@roche.com

If you have a scientific query related to one of Roche's products, please contact us at: pakistan.medical_information@roche.com

Resources
Patient Enrolment Form

Diagnostic Lab Discounts
English
Urdu

Hafsa Shamsie

Managing Director

 

"At Roche, we believe there is an urgent need to address the huge inequities in access to healthcare around the world, especially in countries like ours. Pakistan’s economic crisis, in particular soaring inflation are straining an already burdened healthcare system and making it out of reach for millions of people. The burden of expenses, especially for critical illnesses like cancer, looms large. We know that countless patients are denied the adequate medical treatment they deserve due to financial constraints. We also recognise that we have a responsibility to do something about it. And that is why in 2017, we launched our Patient Support Program, UNMOL, with a focus on oncology related and rare diseases."

References:

1. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7936924 (pinkribbon.org.pk)

2. https://gco.iarc.fr/today/data/factsheets/populations/586-pakistan-fact-sheets.pdf

3. Liaquat National Journal of Cancer Care 2021; 3(1):1-2

4. https://gco.iarc.fr/today/data/factsheets/populations/586-pakistan-fact-sheets.pdf

Manzoor H, Naheed H, Ahmad K, Iftikhar S, Asif M, Shuja J, Sultan N, Ali I, Inayatullah S,Khan YH. Pattern of gynaecological malignancies in south western region of Pakistan:

An overview of 12 years. Biomed Rep. 2017 Nov;7(5):487-491. doi: 10.3892/br.2017.993. Epub 2017 Sep 28. PMID: 29109863; PMCID: PMC5663976

5. Human Papillomavirus and Related Cancers, Pakistan Fact Sheet 2023, ICO/IARC Information Centre on HPV and Cancer

6. https://lymphomacoalition.org/what-is-lymphoma/

7. https://www.msif.org/wp-content/uploads/2020/10/Atlas-3rd-Edition-Epidemiologyreport-EN-updated-30-9-20.pdf (pg: 4,19)

https://www.atlasofms.org/map/global/epidemiology/number-of-people-with-ms#about

8. Farrar MA, Park SB, Vucic S, Carey KA, Turner BJ, Gillingwater TH, et al. Emerging therapies and challenges in spinal muscular atrophy. Ann Neurol [Internet]. 2017 Mar [cited 2017 Sep21];81(3):355–68.

Tisdale S, Pellizzoni L. Disease mechanisms and therapeutic approaches in spinal muscular atrophy. J Neurosci [Internet]. 2015 Jun 10 [cited 2017 Oct 2];35(23):8691–700.

Verhaart IEC, Robertson A, Wilson IJ, artsma-Rus A, Cameron S, Jones CC, et al. Prevalence, incidence and carrier frequency of 5q-linked spinal muscular atrophy - a literature review. Orphanet J Rare Dis[Internet]. 2017 Jul 4 [cited 2017 Sep 21];12(1):124.

https://www.ncbi.nlm.nih.gov/books/NBK533981/

9. https://www.who.int/news-room/fact-sheets/detail/rheumatoid-arthritis

M-PK-00002474
Are you sure?